EN
Non verificato

ENDRA Life Sciences Inc.

Di cosa scriviamo

Attrezzature medico-sanitarieMedicina - VarieMedicina nucleareSaluteScienza
17/07/2026
Attrezzature medico-sanitarie
Salute
Materie prime
Energia
Energia nucleare
Eventi
Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company
1.00
25/06/2026
Mercato azionario
Materie prime
Salute
Energia
Attrezzature medico-sanitarie
Energia nucleare
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
1.00
18/05/2026
Mercato azionario
Industria
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Medicina nucleare
Salute
Farmaceutica
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
1.00
14/05/2026
Industria
Salute
Attrezzature medico-sanitarie
Medicina - Varie
Scienza
Farmaceutica
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility
1.00
31/03/2026
Mercato azionario
Attrezzature medico-sanitarie
Salute
Medicina - Varie
Sanità
Medicina nucleare
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
1.00
25/03/2026
Salute
Attrezzature medico-sanitarie
Tecnica
Tecnologie Varie
Sanità
Biotecnologia
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
1.00
26/02/2026
Industria
Scienza
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Medicina nucleare
Farmaceutica
Salute
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
1.00
20/11/2025
Industria
Scienza
Medicina nucleare
Biotecnologia
Salute
Attrezzature medico-sanitarie
Medicina - Varie
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
1.00
17/11/2025
Salute
Sanità
Medicina - Varie
Scienza
Biotecnologia
Mercato azionario
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0